产品目录
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 120114 | GANT 61 | 500579-04-4 | 98% |  |
| GANT 61 is a small molecule inhibitor of Gli1 and Gli2. | ||||
| 111011 | GSK-1070916 | 942918-07-2 | 98% |  |
| GSK1070916 is a reversible and ATP-competitive inhibitor of Aurora B/C with IC50 of 3 | ||||
| 102206 | GSK269962A | 850664-21-0 | 98% |  |
| GSK269962A(CAS 850664-21-0) is a potent ROCK inhibitor (IC50 values are 1.6 and 4 nM | ||||
| 91415 | Gandotinib(LY2784544) | 1229236-86-5 | 98% by HPLC | -cas-1229236-86-5.png) |
| Gandotinib is an orally bioavailable imidazopyridazine and inhibitor of Janus kinase | ||||
| 91003 | GW 627368 | 439288-66-1 | 98% |  |
| GW 627368X is a potent and selective competitive antagonist of the EP4 receptor with | ||||
| 90731 | GDC-0810 ( Brilanestrant , ARN-810 ) | 1365888-06-7 | ≧98.0% | _1365888-06-7.png) |
| GDC-0810 (Brilanestrant, ARN-810, RG6046) is a selective estrogen receptor degrader ( | ||||
| 62908 | G007-LK | 1380672-07-0 | >98% by HPLC |  |
| G007-LK is specific tankyrase 1/2 inhibitor.G007-LK (66) displayed high selectivity t | ||||
| 62702 | GDC-0349 | 1207360-89-1 | >98% by HPLC |  |
| GDC-0349 is a potent and selective ATP-competitive inhibitor of mTOR. | ||||
| 62003 | Galeterone | 851983-85-2 | 98% by HPLC(254nm or 214nm) |  |
| Galeterone(VN/124-1,TOK001) is a highly selective, multi-targeted, oral small molecul | ||||
| 52804 | Gimeracil | 103766-25-2 | 98% |  |
| Gimeracil(Gimestat) is an inhibitor of dihydropyrimidine dehydrogenase (DPYD), which | ||||
| 52745 | GSK 525762A | 1260907-17-2 | 98% |  |
| GSK 525762A (I-BET 762) is an inhibitor for BET proteins with IC50 of ~35 nM. | ||||
| 52629 | GSK429286A | 864082-47-3 |  | |
| GSK429286A is a selective inhibitor of ROCK1 and ROCK2 with IC50 of 14 nM and 63 nM, | ||||
| 52628 | GSK1059615 | 958852-01-2 | 98% |  |
| GSK1059615 is a dual inhibitor of PI3K/// (reversible) and mTOR with IC50 of 0.4 nM/0 | ||||
| 52627 | GKT137831 | 1218942-37-0 | 98% |  |
| GKT137831 is a novel and specific dual Nox1/Nox4 inhibitor with Ki of 14040 nM and 11 | ||||
| 52618 | GSK2636771 | 1372540-25-4 | 98% by HPLC |  |
| GSK2636771 is a potent, orally bioavailable and selective inhibitor of PI3K (0.89 nM) | ||||
| 52611 | GS-7340 | 379270-37-8 | 98% | |
| GS-7340(Tenofovir alafenamide) is a prodrug of tenofovir (TFV) that more efficiently | ||||
| 52584 | GSK2110183 | 1047634-63-8 | 98% | |
| GSK2110183 is an orally bioavailable, selective, ATP-competitive and potent pan-Akt i | ||||
| 52305 | GW788388 | 452342-67-5 | 98% |  |
| GW788388 is a potent and selective inhibitor of ALK5 with IC50 of 18 nM, also inhibit | ||||
| 52216 | GNF-5 | 778277-15-9 | 98% |  |
| GNF-5, an analogue of GNF-2 with improved pharmacokinetic properties, is a selective | ||||
| 52301 | GNF-2 | 778270-11-4 | 98% |  |
| GNF-2 is a highly selective non-ATP competitive inhibitor of oncogenic Bcr-Abl activi | ||||
| 52216 | GS967 | 1262618-39-2 | 98% | |
| GS967 is a novel, potent, and selective inhibitor of cardiac late sodium current(late | ||||
| 52404 | GBR 12935 dihydrochloride | 67469-81-2 | 98% |  |
| GBR 12935 2Hcl is a potent, and selective dopamine reuptake inhibitor. | ||||
| 52208 | GSK126 | 1346574-57-9 | 98% |  |
| GSK126 is a potent, highly selectiveEZH2 methyltransferaseinhibitor withIC50of 9.9 nM | ||||
| 51805 | GSK503 | 1346572-63-1 | 98% |  |
| GSK-503 is a potent EZH2 inhibitor with potential anticancer activity. Reference: 1. | ||||
| 52304 | GW9662 | 22978-25-2 | 98% |  |
| GW9662 is a selective PPAR antagonist forPPARwithIC50of 3.3 nM, with at least 100 to | ||||
| 52215 | GNE-317 | 1394076-92-6 | 98% |  |
| GNE-317 is a potent, brain-penetrantPI3Kinhibitor | ||||
| S1419 | Genz-123346 | 491833-30-8 | 98% |  |
| Genz-123346 free base is an inhibitor of GL1 synthase that blocks the conversion of c | ||||
| 52017 | Galunisertib(LY2157299) | 700874-72-2 | 98% | -cas-700874-72-2.png) |
| Galunisertib (LY2157299)isselective TGF- receptor kinase inhibitor. Galunisertib was | ||||
| 52018 | GSK3787 | 188591-46-0 | 98% |  |
| GSK3787 is as a selective and irreversible antagonist ofPPARwithpIC50of 6.6, with no | ||||
| 52019 | GSK 2656157 | 1337532-29-2 | 98% |  |
| GSK2656157 is an ATP-competitive and highly selective inhibitor ofPERKwithIC50of 0.9 | ||||